Pharmacogenetics and its clinical implications. Part II. Oxidation polymorphism.
D003647:Debrisoquin / Q000378:metabolism; D006801:Humans; D006900:Hydroxylation; D010084:Oxidation-Reduction; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic; D013034:Sparteine / Q000378:metabolism
D013034:Sparteine; D003647:Debrisoquin